Psychedelics in Research
Matthew emphasizes that current psychedelic research is strictly experimental and requires adherence to specific protocols for conditions like PTSD and depression. He highlights the importance of structured studies and encourages those interested in therapeutic psychedelics to check clinical trial listings for ongoing research. As the conversation unfolds, the potential of psychedelics in mental health treatment is illuminated, offering hope in a challenging landscape.In this clip
From this podcast
Huberman Lab
Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38
Related Questions
What has Andrew Huberman said about psychedelics in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Funding Psychedelic Research?
What has Andrew Huberman said about psychedelics in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Funding Psychedelic Research?
Does Andrew Huberman understand the potential risks of promoting psychedelics to millions in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psilocybin and Innovation, especially considering the possibility of misuse and the current legal status of these substances?